Molina Healthcare (MOH) Competitors

Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, community ranking, institutional ownership, risk, valuation, analyst recommendations and earnings.

Which has stronger earnings & valuation, HUM or MOH?

Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$115.01B	0.25	$2.49B	$11.29	21.41
Molina Healthcare	$39.20B	0.43	$1.09B	$19.69	15.04

Does the media refer more to HUM or MOH?

In the previous week, Humana had 3 more articles in the media than Molina Healthcare. MarketBeat recorded 20 mentions for Humana and 17 mentions for Molina Healthcare. Humana's average media sentiment score of 1.25 beat Molina Healthcare's score of 1.10 indicating that Humana is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	11 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Molina Healthcare	12 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Does the MarketBeat Community favor HUM or MOH?

Humana received 353 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 63.02% of users gave Humana an outperform vote while only 56.96% of users gave Molina Healthcare an outperform vote.

Company	Underperform	Outperform
Humana	Outperform Votes 893 63.02%	Underperform Votes 524 36.98%
Molina Healthcare	Outperform Votes 540 56.96%	Underperform Votes 408 43.04%

Which has more volatility and risk, HUM or MOH?

Humana has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Comparatively, Molina Healthcare has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500.

Do analysts rate HUM or MOH?

Humana currently has a consensus price target of $300.50, suggesting a potential upside of 24.33%. Molina Healthcare has a consensus price target of $363.42, suggesting a potential upside of 22.68%. Given Humana's higher possible upside, equities research analysts plainly believe Humana is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	0 Sell rating(s)	19 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.24
Molina Healthcare	1 Sell rating(s)	7 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.38

Do institutionals and insiders hold more shares of HUM or MOH?

92.4% of Humana shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.3% of Humana shares are held by insiders. Comparatively, 1.1% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Is HUM or MOH more profitable?

Molina Healthcare has a net margin of 2.92% compared to Humana's net margin of 1.18%. Molina Healthcare's return on equity of 27.88% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	1.18%	13.20%	4.47%
Molina Healthcare	2.92%	27.88%	8.33%

Summary

Molina Healthcare beats Humana on 10 of the 19 factors compared between the two stocks.